About: Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables, home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as CardieX Limited and changed its name to Conneqt Health Limited in September 2025. Conneqt Health Limited was founded in 1994 and is based in Sydney, Australia.
Sector: Healthcare
Industry: Medical Devices
Latest price: A$0.02 (+6.25%)
CQTASXConneqt Health Limited
Loading watchlist status…
Conneqt Health Limited share price
CQT price activity
Last Price
Change (24hr)
AUD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
CQT price performance
0%
5D
-19.05%
1M
-67.92%
YTD
-45.16%
1Y
CQT price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
AU-ASX rank
N/ASector Rank
N/ACQT Market Signals